Erdurman F Cüneyt, Durukan A Hakan, Mumcuoğlu Tarkan, Hürmeriç Volkan
Department of Ophthalmology, Gülhane Military Medical Academy and Medical School, Etlik, Ankara, Turkey.
Ocul Immunol Inflamm. 2009 Jan-Feb;17(1):56-8. doi: 10.1080/09273940802491868.
To report the efficacy of intravitreal bevacizumab injection in treatment of macular edema in a case of optic disc vasculitis.
Retrospective case review.
A patient diagnosed with macular edema due to optic disc vasculitis was treated with intravitreal bevacizumab injection.
One week after injection, fundus appearance dramatically improved and macular edema regressed. The patient was followed up for 1 year after injection and there was no recurrence of macular edema.
This case suggests that intravitreal bevacizumab treatment might be effective in the management of macular edema in patients with optic disc vasculitis.
报告玻璃体内注射贝伐单抗治疗视神经盘血管炎所致黄斑水肿的疗效。
回顾性病例分析。
对一名诊断为视神经盘血管炎所致黄斑水肿的患者进行玻璃体内注射贝伐单抗治疗。
注射后一周，眼底外观显著改善，黄斑水肿消退。注射后对患者进行了1年的随访，黄斑水肿未复发。
该病例提示玻璃体内注射贝伐单抗治疗可能对视神经盘血管炎患者的黄斑水肿有效。
